Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions

NCT01952457 is registered in ClinicalTrials.gov with Flanders Medical Research Program as lead sponsor.

NCT NCT01952457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01952457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions
Lead sponsor
Flanders Medical Research Program
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2014
Completion date
December 31, 2019
Enrollment
220 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral vascular disease